Esomeprazole 40mg
Esomeprazole 40mg is a pharmaceutical drug with 23 clinical trials. Currently 3 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 13 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
2
Mid Stage
13
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
13 of 13 finished
0.0%
0 ended early
3
trials recruiting
23
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Vonaprazan Versus Esomeprazole for Healing of LA Grade B or Higher Esophagitis After POEM
A Randomized, Three-Arm Study Comparing Vonaprazan 10 mg, Vonaprazan 20 mg, and Esomeprazole 40 mg for the Healing of LA Grade B or Higher Reflux Esophagitis at 8 Weeks
Efficacy and Safety of Tegoprazan and Minocycline Dual Therapy for Helicobacter Pylori Initial Treatment
Comparison of the Efficacies of Two Novel Dose Dual Therapies in the First-line Helicobacter Pylori Eradication
Optimal Duration of Bismuth Quadruple Therapy for Helicobacter Pylori Eradication in Females As Compared with Males
Clinical Trials (23)
Vonaprazan Versus Esomeprazole for Healing of LA Grade B or Higher Esophagitis After POEM
A Randomized, Three-Arm Study Comparing Vonaprazan 10 mg, Vonaprazan 20 mg, and Esomeprazole 40 mg for the Healing of LA Grade B or Higher Reflux Esophagitis at 8 Weeks
Efficacy and Safety of Tegoprazan and Minocycline Dual Therapy for Helicobacter Pylori Initial Treatment
Comparison of the Efficacies of Two Novel Dose Dual Therapies in the First-line Helicobacter Pylori Eradication
Optimal Duration of Bismuth Quadruple Therapy for Helicobacter Pylori Eradication in Females As Compared with Males
JP-1366 20mg Versus Esomeprazole 40mg in Patients With Erosive Esophagitis
The Efficacy of 10-day and 14-day Bismuth-based Quadruple Therapy in First-line H. Pylori Eradication
Efficacy and Safety of a Triple Eradication Scheme for Helicobacter Pylori Based on Tegoprazan vs Esomeprazole
A Multi-center, Double-blinding, Parallel and Positive-controlled Phase III Clinical Trial for Efficacy and Safety Evaluation of Ilaprazole Sodium for Injection on Prevention of Stress Ulcer Bleeding
Clinical Trial to Evaluate the Safety and Efficacy of JP-1366 in Patients With Erosive Gastroesophageal Reflux Disease
Comparison Between High-dose Amoxicillin Dual Therapy and Pylera Quadruple Therapy in the Treatment of Helicobacter Pylori Infection
A Study to Compare PK, PD and Safety of the AD-206 and Esomeprazole
Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 3)
Efficacy and Safety of LXI-15028 Comparing With Esomeprazole in the Treatment of Erosive Esophagitis
On-demand PPI Therapy is Effective on Controlling Symptoms in Patients With Barrett's Esophagus.
Genotypic Resistance-guided Versus Empirical Therapy for H. Pylori Eradication.
The Effect of Esomeprazole on Type 2 Diabetes
Genotypic Resistance Guided Therapy for Refractory H. Pylori Infection
Study to Confirm the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis
Study to Investigate the Safety, Tolerability and Efficacy of YH4808 in Patients With Reflux Esophagitis
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 23